These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8059798)

  • 1. Efficacy and safety of intravenous cefotaxime for treating pneumonia in outpatients.
    Morales JO; Snead H
    Am J Med; 1994 Aug; 97(2A):28-33. PubMed ID: 8059798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient antibiotic therapy for elderly patients. HIAT Study Group.
    Angel JV
    Am J Med; 1994 Aug; 97(2A):43-9. PubMed ID: 8059801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary bacterial infections in HIV-infected patients: an alternative ambulatory outpatient treatment utilizing intravenous cefotaxime.
    Morales JO; Von Behren L
    Am J Med; 1994 Aug; 97(2A):9-13. PubMed ID: 8059803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing costs and hospital stay for pneumonia with home intravenous cefotaxime treatment: results with a computerized ambulatory drug delivery system.
    Williams DN
    Am J Med; 1994 Aug; 97(2A):50-5. PubMed ID: 8059802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bone and joint infections utilizing a third-generation cephalosporin with an outpatient drug delivery device. HIAT Study Group.
    Mauceri AA
    Am J Med; 1994 Aug; 97(2A):14-22. PubMed ID: 8059796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of serious infections with cefotaxime utilizing an outpatient drug delivery device: global analysis of a large-scale, multicenter trial. HIAT Study Group.
    Poretz DM
    Am J Med; 1994 Aug; 97(2A):34-42. PubMed ID: 8059800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. HIAT Study Group.
    Poretz DM
    Am J Med; 1994 Aug; 97(2A):23-7. PubMed ID: 8059797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections.
    Newton ER; Yeomans ER; Pastorek JG; Soper DE; Hemsell DL
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():195-204. PubMed ID: 8150763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients.
    Yangco BG; Baird I; Lorber B; Noble R; Bermudez R; Silverblatt F; Vasquez G
    J Antimicrob Chemother; 1987 Feb; 19(2):239-48. PubMed ID: 3553135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia.
    Vogel F; Lode H
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():81-6. PubMed ID: 1664833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program.
    Williams DN; Bosch D; Boots J; Schneider J
    Clin Ther; 1993; 15(1):169-79; discussion 168. PubMed ID: 8458046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].
    Manncke K; Springsklee M; Heizmann WR; Sonntag HG
    Med Klin (Munich); 1991 Sep; 86(9):454-60. PubMed ID: 1943983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.
    Segev S; Kitzes R; Rubinstein E; Pitlik S; Samra Y; Shenkman L; Weinberg M
    Isr J Med Sci; 1988 Aug; 24(8):410-4. PubMed ID: 3045049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections.
    Garber GE; Auger P; Chan RM; Conly JM; Shafran SD; Gerson M
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):85-8. PubMed ID: 1730189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
    Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nosocomial pneumonia: comparative multicentre trial between monotherapy with cefotaxime and treatment with antibiotic combinations.
    Fernández-Guerrero M; Gudiol F; Rodriguez-Torres A; Arnau C; Valdés L; Vallvé C
    Infection; 1991; 19 Suppl 6():S320-5. PubMed ID: 1791077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefepime versus cefotaxime for empirical treatment of bacterial pneumonia in HIV-infected patients: an open, randomized trial.
    Cordero E; Bouza E; Ruiz I; Pachon J
    J Antimicrob Chemother; 2001 Oct; 48(4):527-34. PubMed ID: 11581232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies of cefotaxime, administration in intravenous drip infusion, for infectious diseases in the field of obstetrics and gynecology (author's transl)].
    Hagiwara K
    Jpn J Antibiot; 1981 Apr; 34(4):500-6. PubMed ID: 6270398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.
    Chang UI; Kim HW; Wie SH
    Yonsei Med J; 2015 Sep; 56(5):1266-73. PubMed ID: 26256969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of lower respiratory tract infections including pneumonia. Comparative study with i.vl cefotaxime/oral cefixime versus parenteral cefotaxime].
    Vogel F
    Fortschr Med; 1994 Oct; 112(28):395-8. PubMed ID: 7988978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.